dentification of PIK 3 C 3 Promoter Variant Associated ith Bipolar Disorder and Schizophrenia

ackground: Genes involved in phosphoinositide (PI) lipid metabolism are excellent candidates to consider in the pathogenesis of ipolar disorder (BD) and schizophrenia (SZ). One is PIK3C3, a member of the phosphatidylinositide 3-kinase family that maps closely o markers on 18q linked to both BD and SZ in a few studies. ethods: The promoter region of PIK3C3 was analyzed for mutations by single-strand conformation polymorphism analysis and equencing. A case–control association study was conducted to determine the distribution of variant alleles in unrelated patients from hree cohorts. Electromobility gel shift assays (EMSA) were performed to assess the functional significance of variants. esults: Two polymorphisms in complete linked disequilibrium with each other were identified, -432CT and a “C” insert at osition -86. The -432T allele occurs within an octamer containing an ATTT motif resembling members of the POU family of ranscription factors. In each population analyzed, an increase in -432T was found in patients. EMSAs showed that a -432T ontaining oligonucleotide binds to brain proteins that do not recognize -432C. onclusions: A promoter mutation in a PI regulator affecting the binding of a POU-type transcription factor may be involved in BD nd SZ in a subset of patients.

[1]  Richard A. Firtel,et al.  Leading the way: directional sensing through phosphatidylinositol 3-kinase and other signaling pathways , 2003, Journal of Cell Science.

[2]  H. Stefánsson,et al.  Neuregulin 1 and susceptibility to schizophrenia. , 2002, American journal of human genetics.

[3]  Graham L. Collingridge,et al.  Phosphatidylinositol 3 kinase regulates synapse specificity of hippocampal long-term depression , 2002, Nature Neuroscience.

[4]  F. Zhao,et al.  Involvement of Oct-1 in transcriptional regulation of beta-casein gene expression in mouse mammary gland. , 2002, Biochimica et biophysica acta.

[5]  M. Caron,et al.  Phosphoinositide 3-kinase regulates β2-adrenergic receptor endocytosis by AP-2 recruitment to the receptor/β-arrestin complex , 2002, The Journal of cell biology.

[6]  C. Beasley,et al.  Expression of Oct-6, a POU III domain transcription factor, in schizophrenia. , 2002, The American journal of psychiatry.

[7]  Henrik Ewald,et al.  Search for a shared segment on chromosome 10q26 in patients with bipolar affective disorder or schizophrenia from the Faroe Islands. , 2002, American journal of medical genetics.

[8]  M. Boehnke,et al.  Examination of genetic linkage of chromosome 15 to schizophrenia in a large Veterans Affairs Cooperative Study sample. , 2001, American journal of medical genetics.

[9]  C. Dion,et al.  A search for specific and common susceptibility loci for schizophrenia and bipolar disorder: a linkage study in 13 target chromosomes , 2001, Molecular Psychiatry.

[10]  P. Gean,et al.  A Role for the PI-3 Kinase Signaling Pathway in Fear Conditioning and Synaptic Plasticity in the Amygdala , 2001, Neuron.

[11]  J S Sinsheimer,et al.  Chromosome 1 loci in Finnish schizophrenia families. , 2001, Human molecular genetics.

[12]  M. Klein,et al.  Mutation analysis of SYNJ1: a possible candidate gene for chromosome 21q22-linked bipolar disorder , 2001, Molecular Psychiatry.

[13]  M. Caron,et al.  Agonist-dependent Recruitment of Phosphoinositide 3-Kinase to the Membrane by β-Adrenergic Receptor Kinase 1 , 2001, The Journal of Biological Chemistry.

[14]  H. N. Freeman,et al.  Phosphorylation of a Synaptic Vesicle-associated Protein by an Inositol Hexakisphosphate-regulated Protein Kinase* , 2001, The Journal of Biological Chemistry.

[15]  P. De Camilli,et al.  Phosphoinositides in membrane traffic at the synapse. , 2001, Journal of cell science.

[16]  N. Freimer,et al.  Genome screening for linkage disequilibrium in a Costa Rican sample of patients with bipolar-I disorder: a follow-up study on chromosome 18. , 2001, American journal of medical genetics.

[17]  Y. Okubo,et al.  Evidence for association of the myo-inositol monophosphatase 2 (IMPA2) gene with schizophrenia in Japanese samples , 2001, Molecular Psychiatry.

[18]  M. Gladis,et al.  Second stage of a genome scan of schizophrenia: study of five positive regions in an expanded sample. , 2000, American journal of medical genetics.

[19]  W. Berrettini,et al.  Are schizophrenic and bipolar disorders related? A review of family and molecular studies , 2000, Biological Psychiatry.

[20]  G. Prestwich,et al.  A Pleckstrin Homology Domain Specific for Phosphatidylinositol 4,5-Bisphosphate (PtdIns-4,5-P2) and Fused to Green Fluorescent Protein Identifies Plasma Membrane PtdIns-4,5-P2 as Being Important in Exocytosis* , 2000, Journal of Biological Chemistry.

[21]  W. Honer,et al.  Location of a major susceptibility locus for familial schizophrenia on chromosome 1q21-q22. , 2000, Science.

[22]  John P. Rice,et al.  Suggestive evidence of a locus on chromosome 10p using the NIMH genetics initiative bipolar affective disorder pedigrees. , 2000, American journal of medical genetics.

[23]  S. García-Silva,et al.  An Element in the Region Responsible for Premature Termination of Transcription Mediates Repression of c-myc Gene Expression by Thyroid Hormone in Neuroblastoma Cells* , 2000, The Journal of Biological Chemistry.

[24]  T. Matise,et al.  Suggestive linkage of chromosome 10p to schizophrenia is not due to transmission ratio distortion. , 1999, American journal of medical genetics.

[25]  J. Nurnberger,et al.  Chromosome 6 workshop report. , 1999, American journal of medical genetics.

[26]  L R Goldin,et al.  A high-density genome scan detects evidence for a bipolar-disorder susceptibility locus on 13q32 and other potential loci on 1q32 and 18p11.2. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[27]  D. Latchman,et al.  POU family transcription factors in the nervous system , 1999, Journal of cellular physiology.

[28]  M. Chao,et al.  Differential association of phosphatidylinositol-5-phosphate 4-kinase with the EGF/ErbB family of receptors. , 1999, Cellular signalling.

[29]  N. Schork,et al.  A genome-wide search for chromosomal loci linked to mental health wellness in relatives at high risk for bipolar affective disorder among the Old Order Amish. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[30]  L. Pirola,et al.  Structure and function of phosphoinositide 3-kinases. , 1998, Biochimica et biophysica acta.

[31]  T. Crow,et al.  A genome-wide search for schizophrenia susceptibility genes. , 1998, American journal of medical genetics.

[32]  K. Kanyas,et al.  Further evidence for a susceptibility locus on chromosome 10p14-p11 in 72 families with schizophrenia by nonparametric linkage analysis. , 1998, American journal of medical genetics.

[33]  T. Matise,et al.  Genome scan of European-American schizophrenia pedigrees: results of the NIMH Genetics Initiative and Millennium Consortium. , 1998, American journal of medical genetics.

[34]  R. Straub,et al.  A schizophrenia locus may be located in region 10p15-p11. , 1998, American journal of medical genetics.

[35]  A. Toker,et al.  Signalling through the lipid products of phosphoinositide-3-OH kinase , 1997, Nature.

[36]  F. McMahon,et al.  Initial genome scan of the NIMH genetics initiative bipolar pedigrees: chromosomes 1, 6, 8, 10, and 12. , 1997, American journal of medical genetics.

[37]  J. Dixon,et al.  The antibipolar drug valproate mimics lithium in stimulating glutamate release and inositol 1,4,5-trisphosphate accumulation in brain cortex slices but not accumulation of inositol monophosphates and bisphosphates. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[38]  J. Kelsoe,et al.  Linkage studies suggest a possible locus for bipolar disorder near the velo-cardio-facial syndrome region on chromosome 22. , 1997, American journal of medical genetics.

[39]  H. Kobayashi,et al.  Roles of synaptotagmin C2 domains in neurotransmitter secretion and inositol high-polyphosphate binding at mammalian cholinergic synapses. , 1997, Neuroscience.

[40]  J. Brady,et al.  The class III POU factor Brn-4 interacts with other class III POU factors and the heterogeneous nuclear ribonucleoprotein U. , 1997, Brain research. Molecular brain research.

[41]  D. Melton,et al.  A molecular mechanism for the effect of lithium on development. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[42]  L Kruglyak,et al.  Genome scan of schizophrenia. , 1996, The American journal of psychiatry.

[43]  W. Herr,et al.  The POU domain: versatility in transcriptional regulation by a flexible two-in-one DNA-binding domain. , 1995, Genes & development.

[44]  Jurg Ott,et al.  A possible vulnerability locus for bipolar affective disorder on chromosome 21q22.3 , 1994, Nature Genetics.

[45]  E. Nestler,et al.  Chronic electroconvulsive seizure (ECS) treatment results in expression of a long-lasting AP-1 complex in brain with altered composition and characteristics , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[46]  J. Nurnberger,et al.  Chromosome 18 DNA markers and manic-depressive illness: evidence for a susceptibility gene. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[47]  K G Oliver,et al.  Inositol phosphates and cell signaling: new views of InsP5 and InsP6. , 1993, Trends in biochemical sciences.

[48]  Y. Nishizuka Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. , 1992, Science.

[49]  R. MacQuarrie,et al.  Lithium Effects on Inositol Phospholipids and Inositol Phosphates: Evaluation of an In Vivo Model for Assessing Polyphosphoinositide Turnover in Brain , 1992, Journal of neurochemistry.

[50]  R. Jope,et al.  Effects of chronic lithium treatment on protein kinase c and cyclic AMP-dependent protein phosphorylation , 1991, Biological Psychiatry.

[51]  D. Eberhard,et al.  Evidence that the inositol phospholipids are necessary for exocytosis. Loss of inositol phospholipids and inhibition of secretion in permeabilized cells caused by a bacterial phospholipase C and removal of ATP. , 1990, The Biochemical journal.

[52]  T. Sekiya,et al.  Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[53]  P. Sharp,et al.  A nuclear factor that binds to a conserved sequence motif in transcriptional control elements of immunoglobulin genes , 1986, Nature.

[54]  J. Endicott,et al.  A diagnostic interview: the schedule for affective disorders and schizophrenia. , 1978, Archives of general psychiatry.

[55]  E. Robins,et al.  Research diagnostic criteria: rationale and reliability. , 1978, Archives of general psychiatry.

[56]  J. Kelsoe,et al.  Evidence that a single nucleotide polymorphism in the promoter of the G protein receptor kinase 3 gene is associated with bipolar disorder , 2003, Molecular Psychiatry.

[57]  H. Stefánsson,et al.  Association of neuregulin 1 with schizophrenia confirmed in a Scottish population. , 2003, American journal of human genetics.

[58]  P. Schofield,et al.  A genome screen of 13 bipolar affective disorder pedigrees provides evidence for susceptibility loci on chromosome 3 as well as chromosomes 9, 13 and 19 , 2002, Molecular Psychiatry.

[59]  R. Jope,et al.  Mood stabilizers, glycogen synthase kinase-3beta and cell survival. , 2002, Molecular psychiatry.

[60]  G. Moore,et al.  Bipolar disorder: leads from the molecular and cellular mechanisms of action of mood stabilizers. , 2001, The British journal of psychiatry. Supplement.

[61]  Feng Yang,et al.  PI-3 kinase and IP3 are both necessary and sufficient to mediate NT3-induced synaptic potentiation , 2001, Nature Neuroscience.

[62]  P. De Camilli,et al.  PIP kinase Igamma is the major PI(4,5)P(2) synthesizing enzyme at the synapse. , 2001, Neuron.

[63]  O. Mors,et al.  Susceptibility loci for bipolar affective disorder on chromosome 18? A review and a study of Danish families , 1997, Psychiatric genetics.

[64]  F. McMahon,et al.  Initial genome scan of the NIMH genetics initiative bipolar pedigrees: chromosomes 4, 7, 9, 18, 19, 20, and 21q. , 1997, American journal of medical genetics.

[65]  M. Owen,et al.  Linkage Study of Schizophrenia Candidate Regions on Chromosomes 5 q , 6 q , 10 p , and 13 q : Schizophrenia Linkage Collaborative Group III * , 2022 .